Please log in to see the full text of this API!
Ceftazidime
-
ATC:
J01DA11
-
Use:
Lorem
-
Chemical name:
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam
-
Formula:
Lorem ipsum dolor sit amet,
-
MW:546.59 g/mol
-
CAS-RN:72558-82-8
-
InChI Key:ORFOPKXBNMVMKC-DWVKKRMSSA-N
-
InChI:InChI=1S/C22H22N6O7S2/c1-22(2,20(33)34)35-26-13(12-10-37-21(23)24-12)16(29)25-14-17(30)28-15(19(31)32)11(9-36-18(14)28)8-27-6-4-3-5-7-27/h3-7,10,14,18H,8-9H2,1-2H3,(H4-,23,24,25,29,31,32,33,34)/b26-13-/t14-,18-/m1/s1
-
EINECS:276-715-9
-
LD50:6300 mg/kg (M, i.v.); >20 g/kg (M, p.o.);
5800 mg/kg (R, i.v.); >20 g/kg (R, p.o.)
Derivatives
dihydrochloride
-
Use:
-
Formula:
Lorem ipsum dolor sit amet,
-
MW:619.51 g/mol
-
CAS-RN:73547-70-3
Substances Referenced in Synthesis Path
CAS-RN |
Formula |
Chemical Name |
CAS Index Name |
141-97-9 |
C6H10O3 |
acetoacetic acid ethyl ester |
Butanoic acid, 3-oxo-, ethyl ester |
96752-43-1 |
C13H15Cl2N3O3S |
7(R)-amino-3-(1-pyridiniomethyl)-3-cephem-4-carboxylic acid chloride monohydrochloride |
Pyridinium, 1-[(7-amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl)methyl]-, chloride, monohydrochloride, (6R-trans)- |
68672-66-2 |
C32H33N3O5S |
(Z)-2-(1-tert-butoxycarbonyl-1-methylethoxyimino)-2-(2-tritylaminothiazol-4-yl)acetic acid |
4-Thiazoleacetic acid, α-[[2-(1,1-dimethylethoxy)-1,1-dimethyl-2-oxoethoxy]imino]-2-[(triphenylmethyl)amino]-, (Z)- |
23877-12-5 |
C8H15BrO2 |
tert-butyl 2-bromo-2-methylpropionate |
Propanoic acid, 2-bromo-2-methyl-, 1,1-dimethylethyl ester |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Trade Names
Country |
Trade Name |
Vendor |
Annotation |
D |
Lorem |
Lorem
Lorem
,1984 |
|
Lorem |
Lorem
|
|
Lorem ipsum |
|
|
F |
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
GB |
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
I |
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
J |
Lorem |
Lorem
|
|
USA |
Lorem |
Lorem
,1985 |
|
(wfm = withdrawn from market)
Formulations
- Loremipsumdolorsitamet,consetetursadipscingelitr,seddiamnonumy
References
-
- DOS 9 999 999 (Glaxo; appl. 25.5.1979; GB-prior. 26.5.1978).
- US 9 999 999 (Glaxo; 24.3.1981; GB-prior. 26.5.1978).
- GB 9 999 999 (Glaxo; appl. 25.5.1979; GB-prior. 26.5.1978).
- US 9 999 999 (Eli Lilly; 25.6.1985; prior. 27.12.1982, 3.2.1984).
-
intermediate IV:
- US 9 999 999 (Glaxo; 5.2.1985; GB-prior. 13.11.1981).
-
acid chloride of IV:
- EP 999 999 (Glaxo; appl. 28.4.1983; GB-prior. 29.4.1982).
-
intermediate V:
- EP 999 999 (Eli Lilly; appl. 18.6.1984; USA-prior. 20.6.1983).
- EP 99 999 (Glaxo; appl. 16.7.1982; GB-prior. 17.7.1981).
-
salts and crystal modifications:
-
crystalline dihydrochloride:
- US 9 999 999 (Glaxo; 21.8.1984; GB-prior. 2.10.1979).
-
pentahydrate:
- DOS 9 999 999 (Glaxo; appl. 1.10.1980; GB-prior. 2.10.1979).
- GB 9 999 999 (Glaxo; appl. 1.10.1980; GB-prior. 2.10.1979).
- US 9 999 999 (Glaxo; 11.5.1982; appl. 9.9.1980; GB-prior. 2.10.1979).
-
sesquihydrate:
- DOS 9 999 999 (Hoechst; appl. 16.4.1983).
- EP 999 999 (Hoechst; appl. 10.4.1984; D-prior. 16.4.1983).
-
anhydrous crystal modification:
- DOS 9 999 999 (Hoechst; appl. 16.4.1983).
- EP 999 999 (Hoechst; appl. 10.4.1984; D-prior. 16.4.1983).
-
pharmaceutical formulations:
- DOS 9 999 999 (Glaxo; appl. 9.9.1983; GB-prior. 10.9.1982).